- Home
- ANIX vs GDO Comparison
ANIX vs GDO Comparison
Compare ANIX & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIX
- GDO
- Stock Information
- Founded
- ANIX 1982
- GDO 2009
- Country
- ANIX United States
- GDO United States
- Employees
- ANIX N/A
- GDO N/A
- Industry
- ANIX Biotechnology: Pharmaceutical Preparations
- GDO Finance Companies
- Sector
- ANIX Health Care
- GDO Finance
- Exchange
- ANIX Nasdaq
- GDO Nasdaq
- Market Cap
- ANIX 82.7M
- GDO 86.2M
- IPO Year
- ANIX 1987
- GDO N/A
- Fundamental
- Price
- ANIX $3.08
- GDO $11.37
- Analyst Decision
- ANIX Strong Buy
- GDO
- Analyst Count
- ANIX 2
- GDO 0
- Target Price
- ANIX $8.50
- GDO N/A
- AVG Volume (30 Days)
- ANIX 120.2K
- GDO 39.4K
- Earning Date
- ANIX 03-11-2025
- GDO 01-01-0001
- Dividend Yield
- ANIX N/A
- GDO 9.81%
- EPS Growth
- ANIX N/A
- GDO N/A
- EPS
- ANIX N/A
- GDO N/A
- Revenue
- ANIX N/A
- GDO N/A
- Revenue This Year
- ANIX N/A
- GDO N/A
- Revenue Next Year
- ANIX N/A
- GDO N/A
- P/E Ratio
- ANIX N/A
- GDO N/A
- Revenue Growth
- ANIX N/A
- GDO N/A
- 52 Week Low
- ANIX $2.07
- GDO $11.21
- 52 Week High
- ANIX $4.20
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- ANIX 55.10
- GDO 50.77
- Support Level
- ANIX $2.78
- GDO $11.40
- Resistance Level
- ANIX $3.30
- GDO $11.52
- Average True Range (ATR)
- ANIX 0.21
- GDO 0.09
- MACD
- ANIX -0.01
- GDO 0.01
- Stochastic Oscillator
- ANIX 66.15
- GDO 51.52
About ANIX Anixa Biosciences Inc.
Anixa Biosciences Inc, a cancer-focused biotechnology company, developing vaccines and therapies that are focused on critical unmet needs in oncology. The company is developing both diagnostics and therapeutics to detect cancer early, which is curable, and to treat those afflicted once diagnosed. Its segment includes CAR-T Therapeutics; Cancer Vaccines; Anti-Viral Therapeutics and others.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.